GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Leonteq AG (XSWX:LEON) » Definitions » 3-Year EPS without NRI Growth Rate

Leonteq AG (XSWX:LEON) 3-Year EPS without NRI Growth Rate : 0.00% (As of Jun. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Leonteq AG 3-Year EPS without NRI Growth Rate?

Leonteq AG's EPS without NRI for the six months ended in Jun. 2024 was CHF0.30.

During the past 12 months, Leonteq AG's average EPS without NRI Growth Rate was -436.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Leonteq AG was 88.00% per year. The lowest was -71.00% per year. And the median was 3.30% per year.


Competitive Comparison of Leonteq AG's 3-Year EPS without NRI Growth Rate

For the Asset Management subindustry, Leonteq AG's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Leonteq AG's 3-Year EPS without NRI Growth Rate Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Leonteq AG's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Leonteq AG's 3-Year EPS without NRI Growth Rate falls into.



Leonteq AG 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Leonteq AG  (XSWX:LEON) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Leonteq AG 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Leonteq AG's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Leonteq AG Business Description

Industry
Traded in Other Exchanges
Address
Europaallee 39, Zurich, CHE, 8004
Leonteq AG is a Swiss fintech company with a marketplace for structured investment solutions. Based on proprietary modern technology, the company offers derivative investment products and services. Leonteq acts as both a direct issuer of its own products and as a partner to other financial institutions. Leonteq further enables life insurance companies and banks to produce capital-efficient, unit-linked pension products with guarantees. The company has a presence in its home market of Switzerland and Europe, as well as an established footprint in Asia and other countries.

Leonteq AG Headlines

From GuruFocus

Go Epic Health to Begin Clinical Studies for Prostade

By Marketwired Marketwired 03-29-2018

Leone Asset Management Signs Joint Venture

By ACCESSWIRE ACCESSWIRE 04-20-2023

UPDATE:  Go Epic Health to Begin Clinical Studies for Prostade

By Marketwired Marketwired 03-29-2018

Leone Asset Management Releases Q1 Update

By ACCESSWIRE ACCESSWIRE 04-11-2023